Kowal-Bielecka O - Search Results

1

The role of leukotrienes in the pathogenesis of systemic sclerosis.

Chwieśko-Minarowska S, Kowal K, Bielecki M, Kowal-Bielecka O. Chwieśko-Minarowska S, et al. Folia Histochem Cytobiol. 2012 Jul 5;50(2):180-5. doi: 10.5603/fhc.2012.0027. Folia Histochem Cytobiol. 2012. PMID: 22763975 Free article. Review.

2

Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease.

Kowal-Bielecka O, Distler O, Kowal K, Siergiejko Z, Chwiećko J, Sulik A, Gay RE, Łukaszyk AB, Gay S, Sierakowski S. Kowal-Bielecka O, et al. Arthritis Rheum. 2003 Jun;48(6):1639-46. doi: 10.1002/art.11042. Arthritis Rheum. 2003. PMID: 12794832 Free article.

3

Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.

Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S. Kowal-Bielecka O, et al. Arthritis Rheum. 2005 Dec;52(12):3783-91. doi: 10.1002/art.21432. Arthritis Rheum. 2005. PMID: 16320329 Free article.

4

Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications.

Kowal-Bielecka O, Kowal K, Distler O, Gay S. Kowal-Bielecka O, et al. Nat Clin Pract Rheumatol. 2007 Jan;3(1):43-51. doi: 10.1038/ncprheum0375. Nat Clin Pract Rheumatol. 2007. PMID: 17203008 Review.

5

Targeting vascular disease in systemic sclerosis.

Kowal-Bielecka O. Kowal-Bielecka O. Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):401-7. doi: 10.2174/187153006779025793. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 17214586 Review.

6

Impairment of microcirculation in juvenile idiopathic arthritis - studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF.

Gorska A, Kowal-Bielecka O, Urban M, Chlabicz S, Sienkiewicz J, Gorski S. Gorska A, et al. Folia Histochem Cytobiol. 2008;46(4):443-7. doi: 10.2478/v10042-008-0062-z. Folia Histochem Cytobiol. 2008. PMID: 19141396 Free article.

7

Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.

Kowal-Bielecka O, Kowal K, Highland KB, Silver RM. Kowal-Bielecka O, et al. Semin Arthritis Rheum. 2010 Aug;40(1):73-88. doi: 10.1016/j.semarthrit.2008.10.009. Epub 2009 Jan 18. Semin Arthritis Rheum. 2010. PMID: 19152959 Review.

8

Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis.

Bielecki M, Kowal K, Lapinska A, Chwiecko J, Skowronski J, Sierakowski S, Chyczewski L, Kowal-Bielecka O. Bielecki M, et al. Folia Histochem Cytobiol. 2009 Jan;47(3):465-9. doi: 10.2478/v10042-009-0103-2. Folia Histochem Cytobiol. 2009. PMID: 20164033 Free article.

9

Utility of bronchoalveolar lavage in evaluation of patients with connective tissue diseases.

Kowal-Bielecka O, Kowal K, Chyczewska E. Kowal-Bielecka O, et al. Clin Chest Med. 2010 Sep;31(3):423-31. doi: 10.1016/j.ccm.2010.04.002. Clin Chest Med. 2010. PMID: 20692537 Review.

10

Increased production of a proliferation-inducing ligand (APRIL) by peripheral blood mononuclear cells is associated with antitopoisomerase I antibody and more severe disease in systemic sclerosis.

Bielecki M, Kowal K, Lapinska A, Bernatowicz P, Chyczewski L, Kowal-Bielecka O. Bielecki M, et al. J Rheumatol. 2010 Nov;37(11):2286-9. doi: 10.3899/jrheum.100454. Epub 2010 Sep 1. J Rheumatol. 2010. PMID: 20810514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page